Chris Hudson
Director of Access and Innovation, Roche Diagnostics
Biography/Career
Born and educated in London, Chris read Management Science at Kent University, followed by a Post Graduate Diploma in Marketing at Newcastle. In 1991 Chris undertook a full time MBA at Cranfield School of Management.
Chris joined Roche in 1998 and in the last 25 years, he has held several Senior Leadership positions both in the UK & Globally. He is currently the Director of Access and Innovation (A&I).
A&I encompasses: Medical Affairs, Public Affairs, Market Access (incorporating Health Economics) plus two strategic functions, Business Development, and Innovation.
Prior to Roche, Chris worked in Marketing for several international healthcare companies, Multinationals and SMEs, in the UK and USA.
Outside of Roche, Chris is currently an Executive Committee member of the Association of British HealthTech Industries (ABHI), member of DHSCs DIAG (Diagnostics Industry Advisory Group), DHSCs RRG oversight board (Clinical Research Recovery, Resilience and Growth), Co-chair of Life Sciences Council – health data subgroup and now sits on the LSC. Formerly, Chris was the Diagnostic Industry representative on MTAC (Medical Technologies Advisory Committee) for NICE.